Background: Long non-coding RNAs (lncRNAs) have essential regulatory function, yet their roles in colorectal cancer (CRC) are not well understood. Materials and methods: Microarray was applied to detect lncRNAs expression profiles in tumor tissues, liver metastasis and paired adjacent normal tissues of CRC. And using RT-PCR to verify chip results. Results: A total of 10 680 lncRNAs demonstrated differential expressions (fold change ≥2) between tumor tissues and adjacent normal tissues; furthermore there were 2970 lncRNAs, which showed different expression level between CRC tissues with liver metastasis and adjacent normal tissues. Especially, lncRNA-AK098783 expression level was frequently higher in cancerous tissues than corresponding noncancerous tissue. Higher AK098783 expression was significantly correlated with shortened overall survival (P < 0.001) and distant metastasis (P < 0.001). Conclusions: Our results suggest that AK098783 is involved in distant metastasis and dramatically associated with poor prognosis in patients with CRC.
Introduction
Colorectal cancer is one of the most common malignant tumors. There are 1 200 000 newly diagnosed cases each year, and more than 600 000 patients die from the disease (1) . One of the main causes of mortality in patients with colorectal cancer is the occurrence of distant metastasis (2) . With the improvement of clinical diagnosis and treatment technology, the survival rate of patients with colorectal cancer has been improved, but the distant metastasis is still the most important factor affecting the prognosis of patients with colorectal cancer. Therefore, reveal of the mechanisms of distance metastasis of CRC is attracting increased attention in cancer research.
Long non-coding RNA (lncRNA) is RNA molecule that more than 200 bp in length and lacks open reading frame of coding protein (3) . As a new type of regulatory molecules, lncRNAs exert the role of regulating gene expression by affecting transcription and post-transcription (4) . In recent years, many researchers have found that lncRNAs may be an important class of pervasive genes involved in carcinogenesis and metastasis (5) (6) (7) .
Since the global lncRNAs expression profiles in CRC with liver metastasis is still uncovered, at present study, we aim to find novel lncRNAs that related to the liver metastasis of CRC and assessment of its possibility as a molecular marker for predicting metastasis and prognosis. Our data provides candidate diagnostic biomarkers for metastasis and prognosis of colorectal cancer.
Materials and methods

Cell lines and cell culture
The human colorectal cancer cell lines CaCO2, HCT116, Lovo, SW480, SW620 were obtained from the American Type Culture Collection (Manassas, VA, USA). All cell lines were maintained in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum (FBS),100 U/ml penicillin, 100 μg/ml streptomycin and 2 mM L-glutamine (Invitrogen, Carlsbad, CA, USA)
CRC patients and tissue samples collection
In our study, we used 130 human tissue specimens, of which 95 were tumor tissues with a corresponding normal tissue next to the tumor, 35 specimens only have tumor tissues from patients at Sun Yat-Sen University Cancer Center between 2003 and 2008. We performed a cDNA microarray analysis using a panel of three human specimens, which were not included in the above 130 individuals. These three individuals were accompanied by liver metastases of colon cancer, surgical resection of both metastatic lesions and primary lesions. All patients recruited in this study have been pathologically confirmed as colorectal adenocarcinoma and no one received preoperative treatment. The resected tissue samples were immediately frozen in liquid nitrogen, and stored at −80°C until RNA extraction. The clinicopathological characteristics of patient include: age, gender, TNM stage, tumor location (colon or rectum) and differentiation. Patient follow-up was performed every 3 months by inpatient medical records and telephone during the first year after surgery and 6 months thereafter until 30 November 2011. The study was approved by the medical ethics committee of Sun Yat-Sen University Cancer Center and Ethics Committee of the Affiliated Hospital of Jiangnan University and all patients signed informed consent.
RNA extraction and microarray
Briefly, the total RNA extracted by Trizol methods from samples (three CRC tissues, matched adjacent normal tissues and liver metastasis)were used to synthesize cDNA and hybridized to the 12 × 135 K LncRNA Expression Microarray (Arraystar, Rockville, USA). Raw data were extracted using the NimbleScan software (version 2.5). A P value was calculated using the paired t-test. The threshold set for up-and down-regulated genes was a fold change ≥2.0 and a P value <0.05.
Quantitative reverse transcriptase-PCR
For qRT-PCR analysis, the cDNA synthesis and the details of qPCR methods were performed as described before (7) . The primers for AK098783 used in this study were 5′-GAAAAACCACAGGCCCACTA-3′ (forward) and 5′-GCGTCTTCTGCCCT TCATTA-3 (reverse). The relative amount of AK098783 to GAPDH was calculated using the equation 2
ΔCT × 10 000, where ΔCT = CT AK098783-CT GAPDH.
TCGA data analysis
We analyzed the dataset of colorectal cancer in the public database (The Cancer Genome Atlas, TCGA) to further verify the differential expression of lncRNAs in cancer tissues and colorectal tissues. The TCGA data named COADREAD was analyzed by R language (version 2.15.3). All datasets were normalized individually to the base-2 logarithm by linear models for microarray (Limma) and come Multi-array average (RMA) package and annotated by converting different Probe IDs to Gene IDs.
Statistical analysis
Statistical analysis was performed using the SPSS v.16.0 (SPSS Inc., USA). For comparisons, chi-squared tests and Wilcoxon test were performed. The cumulative survival probability was evaluated using the Kaplan-Meier method, and differences were assessed using the log-rank test. To determine independent prognostic factors, the cox multivariate regression analysis was used to adjust for other covariates. A two tailed P value of 0.05 or less was considered statistically significant.
Results
LncRNAs expression profiles in CRC
Arraystar Human lncRNA microarray V2.0 (Agilent_033010 Probe Name version) consisting of 33 045 lncRNAs and 30 215 coding transcripts, was designed for the global profiling of human lncRNAs and protein-coding transcripts. Heat map of hierarchical clustering showed systematic variations in the expression of lncRNAs and protein-coding RNAs between CRC tissues, matched adjacent normal tissues and liver metastasis. A total of 10 680 lncRNAs demonstrated differential expressions (fold change ≥2) between tumor tissues and adjacent normal tissues, In brief, 4500 lncRNAs were over-expressed, whereas 6180 lncRNAs were down-regulated in CRC tumor tissues. We further compared expression profiles between CRC tissues with liver metastasis and paired CRC normal tissues. In total, there were 2970 lncRNAs, which showed different expression level, consisting of 1507 up-regulated and 1463 downregulated lncRNAs (in our supplementary material, data are not shown here).
AK098783 were over expressed in CRC tissues
Through RT-PCR, we validated the results of microarray, and results showed that in 26 highest over expressed LncRNAs, only six of them were consistent with the microarray, which could be the result of high heterogeneity of clinical specimens. And these six lncRNAs (NR_034105, AK129701, AK023516, AK098783, AK021443 and AF119870) were further measured through qRT-PCR in 95 paired CRC tissues and matched adjacent normal tissues. Our data confirmed that these six lncRNAs were all over expressed in CRC tissues (Fig. 1A) . In fact, AK098783 is the only one in which expression level increased along the normal tissue, primary tumor tissue and liver metastases ( Fig. 1B and C) . Furthermore, 86.3% (82/95) of CRC tissues were expression 2.0-fold higher AK098783 than normal tissues. In addition, we investigated expression level of AK098783 in several CRC cell lines. The expression of AK098783 in CRC cell lines was significantly higher than in adjacent normal tissues (Fig. 1D) . We also found that the cell lines with highly invasive ability (such as HCT116, SW620, Lovo) expressing higher level of AK098793 than cell (such as CaCO2) with low invasive ability. These results suggested that high expression level of AK098783 is common in CRC patients and may be related to metastasis. Furthermore, TCGA data analysis confirmed that four of six lnRNAs are consistent with our RT-PCR results (Fig. 2) .
Correlations between AK098783 expression and clinical characteristics
We next to explore whether AK098783 expression was associated with the clinicopathological features of CRC. As shown in Table 1 , correlation between AK098783 expression and clinical characteristics such as age, gender, grade of tumor differentiation and tumor location, TNM stage were examined. The relative expression of AK098783 in tumor tissues range from 0.19 to 84.16, in order to find the best cut-off value for grouping, we use ROC curve method by spss software. Test variable was relative expression of AK098783 in 130 tissues and state variable was survival (use death as end event). We aim to maximize the Youden's index, which is Maximum = Sensitivity + Specificity -1. Then we got 6.55 as cut-off value. The 130 patients were then divided into AK098783-high (n = 79) and low groups (n = 51). The expression level of AK098783 was associated with M categories (P = 0.01) and TNM stage (P = 0.048), but not associated with gender (P = 0.51), age (P = 0.59), tumor location (P = 0.47), T categories (P = 0.32), N categories (P = 0.08) and differentiation (P = 0.64).
Association between AK098783 expression and survival of patient
Survival curves in low and high AK098783 expression groups are shown in Fig. 3 . The overall survival and metastasis free survival were both significantly lower in AK098783-high group compared to those in AK098783-low group (P < 0.001), and the 5-year overall survival rates were 50% in AK098783-high group and 72% in AK098783 low group. It is suggested that high expression level of AK098783 is a significant predictor of subsequent metastasis and death in patient with CRC. Furthermore, univariate analysis identified six prognostic factors: differentiation, T categories, N categories, M categories, TNM stage and AK098783 expression. The other clinicopathological features, such as location, age, and gender were not statistically significant prognosis factors (Table 2 ). Multivariate analysis of the prognosis factors confirmed that high AK098783 expression was a significant independent predictor of poor survival in colorectal cancer (P = 0.026) in addition to presence of TNM stage (P = 0.04) and M categories (P < 0.001) ( Table 2) .
Discussion
Colorectal liver metastases is one of the most important prognostic factors for patient with CRC. Although it is about 15-25% of the patients with liver metastases at the time of diagnosis (8) . The clinical significant of lncRNA expression profiles of CRC liver metastases is yet not fully understood. In the present study, we investigated expression profiles of lnRNAs between CRC tissues, matched adjacent normal tissues and liver metastasis by microarray and qRT-PCR. we confirmed that six lncRNAs were up-regulated in 95 paired CRC tissues. However, AK098783 was the only one of the six lncRNAs which expression level increased along the normal tissue, tumor tissue and liver metastases. Furthermore, by analyzing the association of AK098783 expression level with clinicopathological characteristics and prognosis in CRC, our results revealed that patients with high expression of AK098783 was significantly shorter overall survival time and metastasis free survival time than patients with low AK098783 expression. More important, we found distant metastasis was the clinical factor correlated with AK098783 overexpression in CRC. Together with the increased expression of AK098783 in CRC cell lines, we suggested that AK098783 may involve in the progression of CRC by promoting tumor metastasis. Whether this tendency would be demonstrated in more cancer types need to be further elucidated which strengthened the clinical value of AK098783.
Some previous studies have implicated that lncRNAs was associated with the malignant progression and aggressive biological features of CRC (7, (9) (10) (11) . HOTAIR, the most famous lncRNA molecules is observed up-regulated in CRC and several type of cancer (6, (12) (13) (14) (15) (16) (17) (18) . We also reported a prostate specific lncRNA named PCAT-1 is over expressed in CRC tissue and is an independent prognostic factor in colorectal cancer (7) . All of these suggested the essential role of lncRNA involved in tumor progression. Human AK098783 gene is located in the chromosome Xp11 gene desert between HDAC6 (Histone deacetylase 6), WDR45 (WD repeat domain 45). As we all known, lncRNA tend to regulate the expression of the surrounding genes (19) . Whether or not it is involved in the expression regulation of these two genes, then affect their downstream signaling pathways will be our next step jobs. Although we have confirmed that AK098783 was an independent prognostic factor in CRC and correlated with metastasis by detecting RNA level in clinical specimens, we did not further confirm the speculation that AK098783 may promote CRC cell invasion and metastasis in vitro. The underlying mechanisms need to be further studied.
Conclusion
In conclusion, we revealed the lncRNA expression profiles in colorectal cancer (CRC) with liver metastasis, and confirmed several novel up-regulated lncRNAs in CRC. Furthermore, our results revealed that AK098783 was an independent prognostic factor for patients with CRC. However, the molecular mechanisms of AK098783 involved in CRC need to be further explored. Figure 3 . Kaplan-Meier survival curves of patients with colorectal cancer based on AK098783 expression level. There were 79 patients in AK098783 high expression group and 51 patients in AK098783 low expression group, Patients in the high expression group had significantly poorer overall survival and metastasis free survival than those in low expression group (P < 0.001, log-rank test). HR, hazard ratio; *P < 0.05.
